secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-02-24T23:59:59+00:00
Accession:  0001493152-26-007827
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tampa General Hospital first in Florida to adopt Microbot's LIBERTY robotic system
--------------------------------------------------------------------------------

- Tampa General Hospital (TGH) becomes first Florida health system to adopt LIBERTY Endovascular Robotic System after FDA 510(k) clearance.
- LIBERTY is the only FDA-cleared single-use remotely operated robotic system for peripheral endovascular procedures.
- U.S. peripheral endovascular procedures market approximately 2.5 million annually, representing significant commercial opportunity.
- Limited market release began late 2025; full market release planned at SIR conference in April 2026.
- CEO Harel Gadot cites TGH's innovation culture as endorsement of LIBERTY's value and market relevance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226007827/0001493152-26-007827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226007827/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-007827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer